NURS 6630 FINAL EXAM 4 – QUESTION AND ANSWERS

NURS 6630 FINAL EXAM 4 – QUESTION AND
ANSWERS
 Question 1
1 out of 1 points
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?

Selected A.
Answer: There is too high a risk of serious adverse
side effects.


 Question 2
1 out of 1 points
A 75-year-old male patient diagnosed with Alzheimer’s disease presents with agitation and
aggressive behavior. The PMHNP determines which of the following to be the best
treatment option?

Selected D.
Answer: Citalopram (Celexa) or Escitalopram
(Lexapro)
 Question 3
1 out of 1 points
A group of nursing students seeks further clarification from the PMHNP on how
cholinesterase inhibitors are beneficial for Alzheimer’s disease patients. What is the
appropriate response?

Selected Answer: D.
Both
“A” &
“C.”
A. Acetylcholine (ACh) destruction is inhibited by blocking the enzyme
acetylcholinesterase. B. Effectiveness of these agents occurs in all stages of
Alzheimer’s disease. C. By increasing acetylcholine, the decline in some patients may
be less rapid.
 Question 4
1 out of 1 points
The PMHNP understands that slow-dose extended release stimulants are most appropriate
for which patient with ADHD?

Selected A.
Answer: 8-year-old
patient

, Question 5
1 out of 1 points
An 8-year-old patient presents with severe hyperactivity, described as “ants in his pants.”
Based on self-report from the patient, his parents, and his teacher; attention deficit
hyperactivity disorder (ADHD) is suspected. What medication is the PMNHP most likely to
prescribe?


Selected A.
Answer: Methylphenidate (Ritalin,
Concerta)



 Question 6
1 out of 1 points
A patient with fibromyalgia and major depression needs to be treated for symptoms of
pain. Which is the PMHNP most likely to prescribe for this patient?


Selected Duloxetine
Answer: (Cymbalta)



 Question 7
1 out of 1 points
Mrs. Kenner is concerned that her teenage daughter spends too much time on the
Internet. She inquires about possible treatments for her daughter’s addiction. Which
response by the PMHNP demonstrates understanding of pharmacologic approaches for
compulsive disorders?



Selected D.
Answer: “There are no evidence-based treatments for Internet addiction, but there
are behavioral therapies your daughter can try.”
 Question 8
1 out of 1 points
An adult patient presents with a history of alcohol addiction and attention deficit
hyperactivity disorder (ADHD). Given these comorbidities, the PMHNP determines which of
the following medications may be the best treatment option?

Selected C.
Answer: Atomoxetine
(Strattera)


 Question 9
1 out of 1 points

, Which of the following is a true statement regarding the use of stimulants to treat
attention deficit hyperactivity disorder (ADHD)?

Selected B.
Answer: Signal strength output is increased by dialing up the release of dopamine
(DA) and norepinephrine (NE).




 Question 10
1 out of 1 points
A 71-year-old male patient comes to an appointment with his 65-year-old wife. They are
both having concerns related to her memory and ability to recognize faces. The PMNHP is
considering prescribing memantine (Namenda) based on the following symptoms:

Selected C.
Answer: Amnesia, apraxia,
agnosia



 Question 11
1 out of 1 points
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing
practices when she prescribes the following dose:

Selected A.
Answer: The child will be prescribed
2.5 mg.



 Question 12
1 out of 1 points
The PMHNP is assessing a patient who presents with elevated levels of brain amyloid as
noted by positron emission tomography (PET). What other factors will the PMHNP consider
before prescribing medication for this patient, and what medication would the PMHNP want
to avoid given these other factors?

Selected Answer: D.
Both
“A” &
“B”
A. ApoE4 genotype and avoid antihistamines if possible B. Type 2 diabetes and
avoid olanzapine C. Anxiety and avoid methylphenidate
 Question 13
0 out of 1 points
The PMHNP is attempting to treat a patient’s chronic insomnia and wishes to start with an
initial prescription that has a half-life of approximately 1–2 hours. What is the most